Program Leaders
Daniel J. Fernandes, Ph.D.
Robert K. Stuart, M.D. Scientific Goal
To generate basic information concerning the molecular biology of hematological malignancies and to utilize this information in the design of drug discovery programs and clinical trials Interactions
The Hematologic Malignancies research program comprises researchers representing five different departments at MUSC. Areas of research strength include that members have developed:  Translational studies in both adult and pediatric malignant hematology as well as with bone marrow stem cells,
High-throughput, robotic assays for drug discovery Collaborative research projects with pharmaceutical companies that have resulted in the phase I clinical trials at MUSC of several new anticancer agents The program members meet monthly to discuss research progress and actively collaborate in the development of new research initiatives and mentoring pre and post doctoral students and junior faculty. Contact Us
To find out more about this research program, e-mail the Program Leaders: Daniel J. Fernandes, Ph.D.
fernand@musc.edu Robert K. Stuart, M.D.
stuartk@musc.edu
| 
